tiprankstipranks
Adynxx, Inc. (ADYX)
OTHER OTC:ADYX
US Market
Holding ADYX?
Track your performance easily

Adynxx (ADYX) Stock Price & Analysis

61 Followers

ADYX Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ADYX FAQ

What was Adynxx, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Adynxx, Inc.’s market cap?
Currently, no data Available
When is Adynxx, Inc.’s upcoming earnings report date?
Adynxx, Inc.’s upcoming earnings report date is Nov 14, 2019 which is 1836 days ago.
    How were Adynxx, Inc.’s earnings last quarter?
    Adynxx, Inc. released its earnings results on Aug 14, 2019. The company reported -$0.87 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.87.
      Is Adynxx, Inc. overvalued?
      According to Wall Street analysts Adynxx, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Adynxx, Inc. pay dividends?
        Adynxx, Inc. pays a Notavailable dividend of $1.05 which represents an annual dividend yield of N/A. See more information on Adynxx, Inc. dividends here
          What is Adynxx, Inc.’s EPS estimate?
          Adynxx, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Adynxx, Inc. have?
          Adynxx, Inc. has 5,808,000 shares outstanding.
            What happened to Adynxx, Inc.’s price movement after its last earnings report?
            Adynxx, Inc. reported an EPS of -$0.87 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Adynxx, Inc.?
              Currently, no hedge funds are holding shares in ADYX
              ---

              Adynxx Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Adynxx, Inc.

              Adynxx, Inc. is a clinical stage biopharmaceutical company. It engages in the manufacture, development, and sale of novel, disease-modifying products for the treatment of pain and inflammation. The company was founded by Julien Mamet in October 2007 and is headquartered in San Francisco, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Citius Pharmaceuticals
              TuHURA Biosciences
              ESSA Pharma
              Bioxcel Therapeutics
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis